$MNKD MANNKIND CORP Insider Trading
Get free email notifications about insider trading in MANNKIND CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MANNKIND CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in MANNKIND CORP for free.
IRS Number: 133607736
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MNKD
Company Address: 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE 91362
Phone number: 661-775-5300
MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.
Market Capitalization: $244.02M
Prev close: $0.51
Average Daily Volume: 5,704,320
Days Low: $0.50
Year Low: $0.41
Year High: $2.24
MANNKIND CORP Insiders Active In Last 3 Months
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Castagna Michael | Chief Executive Officer | 3,000 | 1,530 | shares bought: 2,212,959 / shares sold: 0 | STRONG BUY | Mar 08 2021 | 1 month ago |
View all MANNKIND CORP insiders.
MANNKIND CORP Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | MNKD | MANNKIND CORP | Castagna Michael | Chief Executive Off ... | Buy | P | 3.38 | 3,000 | 10,140 | 3,000 | 0 to 3 K |
| Dec 30 2020 | MNKD | MANNKIND CORP | Tross Stuart A | Chief People & Work ... | Payment of Exercise | F | 3.33 | 1,729 | 5,758 | 476,991 | 478.7 K to 477 K (-0.36 %) |
| Dec 10 2020 | MNKD | MANNKIND CORP | Galindo Alejandro | Chief Commercial Of ... | Buy | P | 2.89 | 34,602 | 100,000 | 398,602 | 364 K to 398.6 K (+9.51 %) |
| Dec 10 2020 | MNKD | MANNKIND CORP | Kay Sabrina | Director | Option Exercise | A | 0.00 | 44,117 | 0 | 44,117 | |
| Aug 31 2020 | MNKD | MANNKIND CORP | Alinaya Rosabel Realica | VP, IR & Treasury | Grant | A | 0.00 | 71,000 | 0 | 167,119 | 96.1 K to 167.1 K (+73.87 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Alinaya Rosabel Realica | VP, IR & Treasury | Grant | A | 0.00 | 59,000 | 0 | 96,119 | 37.1 K to 96.1 K (+158.95 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Thomson David | EVP Genl Counsel & ... | Grant | A | 0.00 | 200,000 | 0 | 423,079 | 223.1 K to 423.1 K (+89.65 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Thomson David | EVP Genl Counsel & ... | Grant | A | 0.00 | 164,000 | 0 | 223,079 | 59.1 K to 223.1 K (+277.59 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Alinaya Rosabel Realica | VP, IR & Treasury | Grant | A | 0.00 | 71,000 | 0 | 167,119 | 96.1 K to 167.1 K (+73.87 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Alinaya Rosabel Realica | VP, IR & Treasury | Grant | A | 0.00 | 59,000 | 0 | 96,119 | 37.1 K to 96.1 K (+158.95 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Thomson David | EVP Genl Counsel & ... | Grant | A | 0.00 | 200,000 | 0 | 423,079 | 223.1 K to 423.1 K (+89.65 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Thomson David | EVP Genl Counsel & ... | Grant | A | 0.00 | 164,000 | 0 | 223,079 | 59.1 K to 223.1 K (+277.59 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Kocinsky Joseph | Chief Technology Of ... | Grant | A | 0.00 | 200,000 | 0 | 425,517 | 225.5 K to 425.5 K (+88.69 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Kocinsky Joseph | Chief Technology Of ... | Grant | A | 0.00 | 164,000 | 0 | 225,517 | 61.5 K to 225.5 K (+266.59 %) |
| Aug 31 2020 | MNKD | MANNKIND CORP | Galindo Alejandro | Chief Commercial Of ... | Grant | A | 0.00 | 200,000 | 0 | 364,000 | 164 K to 364 K (+121.95 %) |